Promoting industry ties: ‘trained by the manufacturer’, speaker and consultant roles in practice marketing

Practices that use a drug, device or aesthetic product pick up industry ties along the way. A clinician completes the manufacturer’s training course. The practice earns a tier badge or a spot on the company’s provider locator. A physician speaks at company programs or sits on an advisory board. The company offers to share the cost of a local ad campaign. Each of these can end up in the practice’s marketing, as a line on a bio page, a seal on the homepage or a paid post, and each one says something to patients about skill, independence and judgment.

This guide is written from the practice side: what you can say about these ties, what to disclose, and when money from a manufacturer for your marketing becomes a kickback question. What manufacturers report to CMS and what OIG said about speaker programs is covered in our guide to Open Payments and the Sunshine Act. Gifts and meals between practices are in our guide to gifts and meals for referring physicians, and credential wording in general is in our guide to physician bio pages and board certified claims. For drug maker support in a specialty program, see IBD center marketing.

The short version

• Payments from drug and device makers to physicians and other listed clinician types are reported to CMS and published in a searchable public database (42 USC 1320a-7h). Patients can compare your marketing with that record.
• “Trained by the manufacturer” and “certified provider” are factual claims. They must be true, and the net impression must not suggest a credential, a specialty or a level of skill the training does not give (15 USC 45; FTC Policy Statement on Deception).
• A manufacturer’s badge or locator listing is a statement about your practice by a party with a business interest in it. If a tier reflects purchase volume, say so or do not use it.
• When a clinician who is paid by a company recommends that company’s product in your marketing, the payment is a material connection that must be disclosed clearly and conspicuously (16 CFR 255.5(a)).
• Claims you copy from a manufacturer become your claims. You need your own reasonable basis for them before they run.
• Money or free marketing from a manufacturer for a product a federal health care program pays for is remuneration under the anti-kickback statute (42 USC 1320a-7b(b)), and both sides can be liable.

Your industry ties are already public

The Open Payments statute requires applicable manufacturers of drugs, devices, biologicals and medical supplies to report payments and other transfers of value to covered recipients each year (42 USC 1320a-7h(a)(1)(A)). Covered recipients are physicians, teaching hospitals, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse-midwives, other than those employed by the reporting manufacturer (1320a-7h(e)(6)). The statute directs CMS to publish the data on a website that is searchable and shows the company, the clinician’s name, business address and specialty, the value, date, form and nature of the payment (1320a-7h(c)(1)(C)).

CMS states that the data is publicly accessible through the Open Payments Search Tool, with detailed data for 2019 to 2025 available there. 42 CFR 403.904 sets out the details manufacturers report, including the nature of each payment, such as consulting fees, compensation for serving as faculty or as a speaker, education and food and beverage. The statute excludes transfers of less than 10 dollars unless the yearly total to the clinician exceeds 100 dollars, with both amounts adjusted each year for inflation (1320a-7h(e)(10)(B)(i)).

The practical point for marketing: your website and the public record should tell the same story. A bio that calls a physician an independent expert on a product, while Open Payments shows years of speaker fees from its maker, invites a question your page does not answer. Our Open Payments guide covers how clinicians review and dispute their records before publication.

“Trained by the manufacturer” and “certified provider”

A line such as “Dr. [Name] completed [Company]’s training for [device type]” is a factual claim, and the FTC Act prohibits deceptive acts or practices in commerce (15 USC 45(a)(1)). For ads for drugs, devices and services, 15 USC 52 separately makes it unlawful for any person to disseminate a false advertisement, and 15 USC 55 defines that as one misleading in a material respect, judged by what it says and what it fails to reveal. The FTC Policy Statement on Deception looks at the net impression an ad makes on a consumer acting reasonably.

The net impression is where these lines go wrong. A patient reading “certified” can take it to mean an independent credential with an exam, when it was a one-day vendor course. “Advanced” or “master” training can read as a ranking of skill. State medical board rules make the same point in their own words:

• Texas deems claiming a unique or exclusive skill without substantiation and basis for the claim false, deceptive or misleading advertising (22 TAC 164.3(b)(6)).
• California includes a statement that is likely to mislead or deceive because of a failure to disclose material facts (Business and Professions Code 651(b)(2)).
• Florida bars stating or implying that a physician has received formal recognition as a specialist unless the recognizing agency is approved by the Board, and treats a partial disclosure of relevant facts as misleading (rule 64B8-11.001(2)(b), (2)(f)).

No federal rule sets wording for manufacturer training. We recommend naming the course, the company and the year, using “completed training” rather than “certified” unless the program grants a certification with an assessment, and keeping the line away from board certification and specialty language so the two cannot be confused. Our guide to physician bio pages and board certified claims covers how to word real board credentials.

Provider tier badges and locator listings

Manufacturers of aesthetic, dental and orthopedic products run provider programs with tiers, seals and a “find a provider” map. Under the FTC Endorsement Guides, an endorsement is a message consumers are likely to believe reflects the opinions or findings of a party other than the advertiser, and the name or seal of an organization can be one (16 CFR 255.0(b)). An endorsement may not convey any express or implied representation that would be deceptive if made directly by the advertiser (16 CFR 255.1(a)).

Apply that to a tier badge. If the practice could not honestly say “we are the best injectors in the region”, a badge that implies it cannot say it either. Where the tier is based on how much product the practice buys, the badge measures purchasing, not outcomes or expertise. No federal rule requires a particular disclosure here. We recommend reading the program terms before displaying a badge, and either explaining the basis next to it (for example, “Program tier based on annual treatment volume”) or leaving it off. A locator listing on the manufacturer’s site is the manufacturer’s own advertising, but if you link to it as proof of quality, the same analysis applies to how you describe it.

Speaker, consultant and advisory roles on a bio page

Listing a real role is not a problem in itself. “Consultant to [Company], 2024 to present” on a physician’s bio is accurate, and it is consistent with what Open Payments will show. The issue arises when the same clinician recommends that company’s product in the practice’s own marketing: a blog post comparing treatment options, a video on a procedure page, a social post about a new device.

Under 16 CFR 255.5(a), when a connection between the endorser and the seller might materially affect the weight or credibility of an endorsement and the audience would not reasonably expect it, the connection must be disclosed clearly and conspicuously. Material connections can include a business relationship, monetary payment and free or discounted products, whether or not the advertiser requires an endorsement in return. A patient reading a physician’s comparison of devices would not expect the physician to be paid by one of the makers. Put the disclosure in the content itself, next to the recommendation, not only on the bio page. For the reporting side of paid content, see our guide to healthcare influencer marketing.

Roles end. We recommend reviewing the industry relationships on each bio at least once a year and when a contract ends, and dating each role so readers can see whether it is current.

Repeating the manufacturer’s claims

Manufacturers supply patient brochures, before and after images, claim sheets and ready-made social posts. Once these appear on your site under your name, you are the one disseminating them, and 15 USC 52 applies to any person who disseminates a false advertisement for a drug, device or service. The FTC Policy Statement Regarding Advertising Substantiation says advertisers must have a reasonable basis for objective claims before they are disseminated. Ask the company for the support behind each claim you use, and keep it.

Check device claims against the product’s cleared or approved use, and do not extend them to indications it does not have. Our guide to medical device marketing claims covers cleared, approved and intended use wording. Before and after images from a manufacturer show other providers’ patients, and California bars images that do not accurately depict the results of the procedure being advertised (651(b)(3)(A)). We recommend labeling any manufacturer image with its source, or using only your own patients’ images with their signed authorization.

When a manufacturer pays for your marketing

Co-op advertising funds, a free website banner, a sponsored patient event, a paid local ad that lists your practice as a provider, a professional video shoot: these are things of value. The anti-kickback statute makes it a felony to knowingly and willfully solicit or receive any remuneration, directly or indirectly, in cash or in kind, in return for purchasing, ordering or recommending any item for which payment may be made in whole or in part under a federal health care program (42 USC 1320a-7b(b)(1)(B)). The offer or payment side is covered in 1320a-7b(b)(2).

OIG’s November 16, 2020 Special Fraud Alert on speaker programs states that if the requisite intent is present, both the company and the health care professionals may be subject to criminal, civil and administrative enforcement actions. Its list of suspect characteristics includes companies selecting speakers or attendees based on past or expected revenue from prescribing or ordering the company’s products, paying speakers more than fair market value, and attendees with no legitimate business reason to attend, including employees or medical professionals who are members of the speaker’s own medical practice. If your physician speaks for a company, do not fill the room with your own staff.

The federal statute reaches items a federal health care program pays for. A cash-pay aesthetic product may fall outside it, but state anti-kickback and fee-splitting laws differ and can reach all payers. We recommend that any marketing support from a manufacturer be in writing, reviewed by a health care attorney before you accept it, and never tied to how much product you buy or prescribe.

Questions to ask before an industry tie goes into your marketing

• Is the statement true today, and can we show the document behind it?
• Could a patient read “certified”, “advanced” or a tier name as an independent credential or a ranking of skill?
• What is the badge or tier based on: training, an assessment, or purchase volume?
• Does the clinician recommending a product receive anything from its maker, and is that disclosed next to the recommendation?
• Does the bio match the clinician’s Open Payments record?
• Do we have our own support for each claim taken from manufacturer materials?
• Is anyone paying for this content or ad other than the practice, and has an attorney reviewed that arrangement?

Use and avoid

• Use: “Completed [Company]’s training for [device type], 2025.”
• Avoid: “Certified expert” for a vendor course with no assessment.
• Use: a tier badge with a plain line explaining what the tier is based on.
• Avoid: a tier badge placed among accreditation seals with no explanation.
• Use: “Dr. [Name] is a paid consultant to [Company]” next to their comparison of devices.
• Avoid: an independent sounding review of a product from a clinician the maker pays.
• Use: a written, attorney-reviewed agreement for any manufacturer marketing support.
• Avoid: free ads or videos from a company whose products you order and bill to Medicare.

An illustration

This example is invented. [Practice name], an aesthetic and dermatology practice, has a homepage seal reading “Elite Provider” from an injectable maker, a bio describing the medical director as “certified in advanced techniques”, and a blog post by the medical director comparing two fillers. The medical director is a paid speaker for the maker of one of them. A sales representative offers to fund a local social ad campaign featuring the practice.

The practice reads the program terms and finds the tier is based on annual purchase volume. It moves the seal to the treatment page with a line stating the basis. The bio now reads “Completed [Company]’s advanced injection training, 2025” and lists the speaker role with its start year. The blog post gets a disclosure above the comparison: “Dr. [Name] is a paid speaker for [Company], which makes one of the products discussed.” The practice declines the ad funding until its attorney has reviewed the offer under the state’s anti-kickback law, since the products are cash-pay and the federal statute may not apply.

Checklist

• List each manufacturer training, badge, tier, locator listing and paid role mentioned anywhere in your marketing.
• Keep the document behind each one and the date it was earned.
• Replace “certified” with “completed training” unless there was an assessment and a certificate.
• Read the terms of each provider program and explain or remove tier badges based on purchasing.
• Disclose paid relationships next to any recommendation of the paying company’s product.
• Check each clinician’s Open Payments record against their bio.
• Keep support for each claim taken from manufacturer materials, within the product’s cleared or approved use.
• Label manufacturer images with their source, or use your own patients’ images with authorization.
• Get attorney review before accepting any marketing support from a manufacturer.
• Review industry relationships on bios once a year and when a role ends.

How we help

We build websites, local and organic search, Google Ads and lead generation and an AI front desk for independent practices. For a practice with manufacturer ties, that means bio pages and treatment pages that describe training and roles accurately, with disclosures placed where patients read the recommendation. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. For the wider rules, see our healthcare marketing rules guide.

Sources

• 42 USC 1320a-7h: Transparency reports and reporting of physician ownership or investment interests
• 42 CFR 403.904: Reports of payments or other transfers of value to covered recipients
• CMS: Open Payments Data (last modified July 9, 2026)
• CMS: Open Payments Covered Recipients (last modified September 2, 2026)
• 42 USC 1320a-7b: Criminal penalties for acts involving federal health care programs (anti-kickback statute, subsection (b))
• HHS OIG: Special Fraud Alert: Speaker Programs (November 16, 2020)
• 15 USC 45: Unfair methods of competition unlawful
• 15 USC 52: Dissemination of false advertisements
• 15 USC 55: Additional definitions
• FTC Policy Statement on Deception (October 14, 1983)
• FTC Policy Statement Regarding Advertising Substantiation (1984)
• 16 CFR 255.0: Purpose and definitions (Endorsement Guides)
• 16 CFR 255.1: Endorsements, general considerations
• 16 CFR 255.5: Disclosure of material connections
• California Business and Professions Code section 651
• 22 Texas Administrative Code 164.3: Prohibited acts or omissions in advertising (Texas Medical Board)
• Florida Administrative Code rule 64B8-11.001: Advertising (Board of Medicine)

More in Healthcare marketing rules